Loading company details...
Beta
Latest Form 4 (Jun 29, 2026): James David Clark (SVP, Cont & Chief Acct Officer): Tax Withholding of 454 shares, $41.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | James David Clark, SVP, Cont & Chief Acct Officer | Tax Withholding | 454 | $41.3K |
| Jun 1, 2026 | Brian Newman, EVP, Chief Financial Officer | Tax Withholding | 2,478 | $225.4K |
| Jun 1, 2026 | Amy Compton-Phillips, EVP, Chief Medical Officer | Tax Withholding | 7,618 | $693.1K |
| May 22, 2026 | Fernando Aguirre | Disposition to Issuer | 30,437 | $2.85M |
| May 21, 2026 | Larry Robbins | Sale | 1,983,387 | $187.33M |
| May 15, 2026 | John E. Gallina | Grant/Award | 1,448 | $140.6K |
| May 15, 2026 | Michael F. Mahoney | Grant/Award | 1,737 | $168.7K |
| May 15, 2026 | Fernando Aguirre | Grant/Award | 1,563 | $151.8K |
| May 15, 2026 | Jeffrey R. Balser | Grant/Award | 2,058 | $199.9K |
| May 15, 2026 | J. Scott Kirby | Grant/Award | 1,447 | $140.6K |